What is it about?
To compare ocular surface changes induced via glaucoma treatment in patients using fixed combinations of bimatoprost 0.03%/timolol 0.50%, timolol 0.50% or bimatoprost 0.01% eye drops.
Featured Image
Photo by Sergey Fediv on Unsplash
Why is it important?
In the International Literature it is important to compare the impact on the ocular surface of these glaucoma drugs.
Perspectives
Read the Original
This page is a summary of: Ocular Surface Disease Index in Glaucomatous Patients Treated with Bimatoprost, Open Journal of Ophthalmology, January 2014, Scientific Research Publishing, Inc,,
DOI: 10.4236/ojoph.2014.42007.
You can read the full text:
Contributors
The following have contributed to this page